Advertisement

Gelbfieber

  • H. J. Knüttgen
Chapter
Part of the Infektionskrankheiten book series (INNEREN)

Zusammenfassung

Das Gelbfieber, eine der quarantänepflichtigen Krankheiten, ist eine akute Virusinfektion von kurzer Dauer, die in den tropischen Gebieten Afrikas und Amerikas heimisch ist. Das natürliche Virusreservoir wird in Affen u. a. Säugetieren der Wälder durch bestimmte Stechmücken kontinuierlich unterhalten. Der Erreger wird durch infizierte Waldmücken auf einzelne Menschen übertragen („Dschungelgelbfieber“). Nach Einschleppung des Virus in Städte können durch Übertragung von Mensch zu Mensch verheerende Epidemien auftreten. Dieses „Stadtgelbfieber“ wird am häufigsten durch Aedes aegypti verbreitet. Nur ein geringer Teil der infizierten Menschen entwickelt nach einer Inkubationszeit von 3—6 Tagen das voll ausgebildete Krankheitsbild mit Fieber, Ikterus, Albuminurie und Blutungen. Die Letalität aller Infektionsfälle bleibt meist unter 10%, die Sterblichkeit der klinisch manifesten Erkrankungen ist dagegen hoch. Die Infektion hinterläßt eine dauernde Immunität. Auch nach schwerem Gelbfieber bleiben Organschäden nicht zurück.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Anderson, C.R., and G.H. Wattley: The isolation of yellow fever virus from human liver obtained at autopsy. Trans, roy. Soc. trop. Med. Hyg. 49, 580—581 (1955).Google Scholar
  2. Baruch, E.: Electron microscopic study of spinal cord of mice infected with yellow fever virus. J. Ultrastruct. Res. 9, 209—224 (1963).Google Scholar
  3. Baruch, E., L. Carbonell, and J. Weibel: Fine structure of Councilman bodies in the liver of aluatta seniculus seniculus L. infected with yellow fever virus. Exp. Cell Res. 29, 50—53 (1963).PubMedGoogle Scholar
  4. Bayer, M.E., u. G. Nielsen: Zur Morphologie des Gelbfiebervirus. (Kurze Mitteilung.) Arch. ges. Virusforsch. 11, 303—306 (1962).Google Scholar
  5. Bearcroft, W. G. C.: The histopathology of the liver of yellow fever infected rhesus monkeys. J. Path. Bact. 74, 295—303 (1957).Google Scholar
  6. Bearcroft, W. G. C.: Cytological and cytochemical studies on the livers of yellow fever infected Rhesus monkeys. J. Path. Bact. 80, 19—31 (1960).PubMedGoogle Scholar
  7. Bearcroft, W. G. C.: Studies on the livers of yellow fever infected African monkeys. J. Path. Bact. 83, 49—58 (1962).PubMedGoogle Scholar
  8. Bearcroft, W. G. C.: Electron microscopic studies on the livers of yellow fever infected monkeys. J. Path. Bact. 83, 59—64 (1962).PubMedGoogle Scholar
  9. Becker, H., u. H. Lieske: Allergische Reaktion nach Gelbfieberimpfung. Z. Tropen- med. Parasit 8, 4—7 (1957).Google Scholar
  10. Beet, E.A.: Encephalitis after yellow fever vaccination. Brit, med. J. 1955 I, 226—227.Google Scholar
  11. Berdonneau, R C. Serié, R. Panthier, C. Hannoun, S.C. Papa- ioannou, et P. Georgieff: Sur l’épidémie de fièvre jaune de l’année 1959 en Ethiopie (Frontière soudano-éthiopienne). Bull. Soc. Path. exot. 54, 276—283 (1961).Google Scholar
  12. Bergold, G.J., and J. Weibel: Demonstration of yellow fever virus with the electron microscope. Virology 17, 554 to 562 (1962).Google Scholar
  13. Berry, G.P., and S.F. Kitchen: Yellow fever accidentally contracted in the laboratory. A study of seven cases. Amer. J. trop. Med. 11, 365—434 (1931).Google Scholar
  14. Bonnel, P.H.: International regulation of yellow fever vaccination. In: Yellow Fever Vaccination. Wld Hlth Org. Geneva 1956.Google Scholar
  15. Boorman, J.P. T., and J. S. Porterfield: A small outbreak of yellow fever in the Gold Coast. Trans, roy. Soc. trop. Med. Hyg. 51, 439—449 (1957).Google Scholar
  16. Boshell, M.J.: Marche de la fièvre jaune salvatique vers Ies régions du nord-ouest de TAmérique centrale. Bull. Wld Hlth Org. 16, 431—436 (1957).Google Scholar
  17. Bres, P., A. Lacan, R. Diop Issa Michel, P. Peretti, et C. Vidal: Résultats des campagnes de vaccination antiamarile en République du Sénégal. Bull. Soc. Path. exot. 55, 1038—1043 (1962).Google Scholar
  18. Bugher, J.C.: The demonstration of yellow fever antibodies in animal sera by the intracerebral protection test in mice. Amer. J. trop. Med. 20, 809 (1940).Google Scholar
  19. Bugher, J.C., J. Boshell-Manrique, M. Roca Garcia, and E. Osorno Mesa: Epidemiology of jungle yellow fever in eastern Colombia. Amer. J. Hyg. 39, 16 (1944).Google Scholar
  20. Bugher, J.C.: The mammalian host in yellow fever. In: Yellow Fever (G.K. Strode, edit.).,New York 1951.Google Scholar
  21. Bugher, J.C.: Jungle yellow fever. In: Yellow fever. A symposium in commemoration of Carlos Juan Finlay. Philadelphia 1955.Google Scholar
  22. Bustamente, M.E.: La fiebre amarilla en Mexico y su origen en America.,Mexico 1958.Google Scholar
  23. Cannon, D.A.: Encephalitis after yellow fever vaccination. Brit. med. J. 1955 II, 1090.Google Scholar
  24. Cannon, D. A., F. Dewhurst, and P.D. Meers: Mass vaccination against yellow fever by scarification with 17 D strain vaccine. Ann. trop. Med. Parasit. 51, 256—263 (1957).PubMedGoogle Scholar
  25. Carter, H.R.: Yellow fever, an epidemiological and historical study of its place of origin. Baltimore 1931.Google Scholar
  26. Casals, J., and L.V. Brown: Hemagglutination with arthropod-borne viruses. J. exp. Med. 99, 429—449 (1954).PubMedCentralPubMedGoogle Scholar
  27. De Castro Freire: Meningo-encefalite post vacinagao contra a febre amarela. Rev. port. Pediat. 18, 65—71 (1955).Google Scholar
  28. Chabaud, M. A., et M. Ovazza: La fièvre jaune dans la Fédération d’Ethiopie et d’Erythrée. Bull. Wld Hlth Org. 19, 7—21 (1958).Google Scholar
  29. Chagas, E., e L. de Freitas: Electrocardiogramma na febre amarella. Inst. Osw. Cruz, Suppl. das Memorias 7, 72—78 (1929).Google Scholar
  30. Clarke, D.H.: Antigenic variation and geographic distribution of arboviruses. An. Microbiol. (Rio de J.) 11, 143—148 (1963).Google Scholar
  31. Combescot de Marsaguet, G.S., et J. Thomas: Les états encéphalo-méningés succédants aux vaccinations antivariologiques et anti- amariles associées ou isolées. Méd. Trop. 21, 115—128 (1961).Google Scholar
  32. Couto, M., u. H. da Rocha Lima: Gelbfieber. In: Menses Hdb. Tropenkrkh. 5, 1, 729—808 (1929).Google Scholar
  33. Daberkow, K., u. H. J. Knüttgen: Das periphere Blutbild von Rhesusaffen nach Infektion mit Gelbfieberstämmen unterschiedlicher Pathogenität. Z. Tropenmed. 17, (1966) im Druck.Google Scholar
  34. Dick, G.W.A.: Primary evaluation of immunizing power of chick-embryo 17 D yellow fever vaccine inoculated by scarification. Amer. J. Hyg. 55, 140 (1952).PubMedGoogle Scholar
  35. Dick, G.W.A.: Vaccination by scarification with 17 D chick-embryo vaccine. In: Yellow fever vaccination. Wld Hlth Org. Geneva 1956.Google Scholar
  36. Downs, W.: The reappearance of yellow fever in Trinidad after 40 years of absence. In: Yellow fever. A symposium in commemoration of Carlos Juan Finlay. Philadelphia 1955.Google Scholar
  37. Downs, W.G., C.R. Anderson, and L. Spence: Isolation of yellow fever virus from a human patient on the twelfth day of illness. Trans, roy. Soc. trop. Med. Hyg. 49, 577 to 579 (1955).Google Scholar
  38. Durieux, C.: Preparation of yellow fever vaccine at the Institut Pasteur, Dakar. In: Yellow fever vaccination. Wld Hlth Org. Geneva 1956.Google Scholar
  39. Durieux, C., and R. Koerber: Post vaccination immunity with yellow fever vaccine of the Institut Pasteur, Dakar. In: Yellow fever vaccination. Wld Hlth Org. Geneva 1956.Google Scholar
  40. Durieux, C.: Vaccination technique with yellow fever vaccine of the Institut Pasteur, Dakar. In: Yellow fever vaccination. Wld Hlth Org. Geneva 1956.Google Scholar
  41. Eklund, C.M.: Encephalitis infantil en Costa Rica y Honduras después des empleo de la vacuna Dakar contra la fiebre amarilla. Bol. Ofic. sanit. panamer. 35, 505—516 (1953).PubMedGoogle Scholar
  42. Fabiyi, A., and F.N. Macnamara: The effect of heterologous antibodies on the serological conversion rate after 17 D yellow fever vaccination. Amer. J. trop. Med. Hyg. 11, 817—821 (1962).Google Scholar
  43. Feitel, M., E.H. Watson, and K.W. Cochran: Encephalitis after yellow fever vaccination. Pediatrics 23, 956—958 (1960).Google Scholar
  44. Fox, J.P., E.H. Lennette, C. Manso, and J.R. Souza Aguiar: Encephalitis in man following vaccination with 17 D yellow fever virus. Amer. J. Hyg. 36, 117 (1942).Google Scholar
  45. Fuhrmann, G.: Serumproteine und Serumenzyme bei einigen tropischen Erkrankungen. Z. Tropenmed. Parasit. 13, 53 (1962).Google Scholar
  46. Haagen, E., u. M. Theiler: Untersuchungen über das Verhalten des Gelbfiebervirus in der Gewebekultur. Mit besonderer Berücksichtigung seiner Kultivierbarkeit. Zbl. Bakt., I. Abt. Orig. 125,145—158 (1932).Google Scholar
  47. Haagen, E.: Viruskrankheiten des Menschen.,Darmstadt 1963.Google Scholar
  48. Haas, L.: Encephalitis after yellow fever vaccination. Brit. med. J. 1954 II, 992—993.Google Scholar
  49. Hanson, H.: Observations on the age and sex incidence of deaths and recoveries in the yellow fever epidemic in the department of Lambayeke, Peru, in 1921. Amer. J. trop. Med. 9, 233 to 239 (1929).Google Scholar
  50. Hahn, R. G.: Combined yellow fever smallpox vaccine for cutaneous application. Amer. J. Hyg. 54, 50—70 (1951).PubMedGoogle Scholar
  51. Kerr, J.A.: The clinical aspects and diagnosis of yellow fever. In: Yellow Fever (J.K. Strode, edit.).,New York 1951.Google Scholar
  52. Kerr, J.A.: Yellow fever vaccination by scarification. Trans, roy. Soc. trop. Med. Hyg. 51, 559 (1957).Google Scholar
  53. Kouwenaar, W.: The reaction to yellow fever vaccine (17D), particularly in allergic individuals. Docum. Med. geogr. trop. (Amst.) 5, 75—84 (1953).Google Scholar
  54. Kirk, R.: An epidemic of yellow fever in the Nuba Mountains, Anglo-Egyptian Sudan. Amer. J. trop. Med. Parasit. 35, 67 (1941).Google Scholar
  55. Klotz, O., and T.H. Belt: The pathology of the liver in yellow fever. Amer. J. Path. 6, 663 (1930).PubMedGoogle Scholar
  56. Klotz, O., and T.H. Belt: Regeneration of liver and kidney following yellow fever. Amer. J. Path. 6, 689 (1930).PubMedGoogle Scholar
  57. Kumm, H.W., and H. W. Laemmert: A study of the concentration of yellow fever virus which will infect certain species of Aedes mosquitoes. Amer. J. trop. Med. 30, 749—755 (1950).PubMedGoogle Scholar
  58. Laemmert, H. W., L. de Castro Ferreira, and R. M. Taylor: Epidemiological study of jungle yellow fever in endemic area in Brazil; investigations of vertebrate hosts and arthropod vectors. Amer. J. trop. Med. Suppl. 26, 23—69 (1946).Google Scholar
  59. Lartigaut, M., et L. Couteau: Encéphalite bénigne après vaccination contre Ia fièvre jaune par Ie vaccin atténué en tissue embryonnaire. J. Méd. Bordeaux 131, 506—507 (1954).PubMedGoogle Scholar
  60. Lartigaut, M., et D. Lartigaut: Encéphalite vaccinale du nourrisson après vaccination contre Ia fièvre jaune. J. Méd. Bordeaux 131, 1388 (1954).Google Scholar
  61. Lepine, P., zit. nach J. Stuart, 1956. In: Yellow fever vaccination. Wld Hlth Org. Genf 1956.Google Scholar
  62. Lins, S.A.: Contribui9ao ao estudo clinico da febre amarella. Arq. Hig. Rio de Janeiro 3, 195—404 (1929).Google Scholar
  63. Macnamara, F. N.: Reactions following neurotropic yellow fever vaccine given by scarification in Nigeria. Trans, roy. Soc. trop. Med. Hyg. 47,199—208 (1953).Google Scholar
  64. Macnamara, F. N.: Uganda S and yellow fever viruses: A slight relationship shown by experiments in rhesus monkeys and white mice. Brit. J. exp. Path. 34, 392—399 (1953).PubMedGoogle Scholar
  65. Macnamara, F. N.: Isolation of the virus as a diagnostic procedure for yellow fever in West Africa. Bull. Wld Hlth Org. 11, 391—401 (1954).Google Scholar
  66. Macnamara, F. N.: A clinico-pathological study of yellow fever in Nigeria. West Afr. Med. J. 6, 137—146 (1957).Google Scholar
  67. Macnamara, F.N., D.W. Horn, and J.S. Porterfield: Yellow fever and other arthropod borne viruses: A consideration of serological surveys made in South Western Nigeria. Trans, roy. Soc. trop. Med. Hyg. 53, 202—212 (1959).Google Scholar
  68. Mathis, C., A.W. Sellards, et J. Laigret: Sensibilité du macacus rhesus au virus de la fièvre jaune. C.R. Acad. Sei. (Paris) 186, 604 (1928).Google Scholar
  69. Meers, P.D.: Yellow fever vaccination by scarification with the 17 D strain; an appreciation of the present position. Trans, roy. Soc. trop. Med. Hyg. 51, 338—345 (1957).Google Scholar
  70. Meers, P.D.: Yellow fever vaccination by scarification. Trans, roy. Soc. trop. Med. Hyg. 52,188 (1958).Google Scholar
  71. Meers, P.D.: Combined smallpox 17D yellow fever vaccine for scratch vaccination. Trans, roy. Soc. trop. Med. Hyg. 53, 196—201 (1959).Google Scholar
  72. Meers, P.D.: Further observations on 17 D yellow fever vaccination by scarification with and without simultaneous smallpox vaccination. Trans, roy. Soc. trop. Med. Hyg. 54, 493—501 (1960).Google Scholar
  73. Miranda, G.: Comportamiento de algunas pruebas de icterieia en la fiebre amarilla. Rev. Biol, trop. (S. José) 1, 147 (1953).Google Scholar
  74. Nauck, E.G.: Gelbfieber. In: Handbuch der Inn. Med. I, 1/593—613. Berlin-Heidelberg- New York: Springer 1952.Google Scholar
  75. Nogueira, P.: The early history of yellow fever: The Finlay period. In: Yellow fever. A symposium in commemoration of Carlos Juan Finlay. Philadelphia 1955.Google Scholar
  76. Pan American Sanitary Bureau. Yellow Fever Conference 21.—22. Dec. 1954. Amer. J. trop. Med. Hyg. 4, 571—648 (1955).Google Scholar
  77. Panthier, R.: A propos de quelques cas de réactions tardives observées chez Ies nourrissons après vaccination antiamarile (17 D). Bull. Soc. Path. exot. 49, 477—494 (1956).PubMedGoogle Scholar
  78. Panthier, R., et R. A. Husson: Vaccination antiamarile (17D) et allergie. Bull. Soc. Path. exot. 50, 23—28 (1957).PubMedGoogle Scholar
  79. Panthier, R., R.A. Husson, et C. Hannoun: Les allergiques et la vaccination antiamarile 17D. Résultats complémentaires. Bull. Soc. Path, exot. 52, 759—764 (1959).Google Scholar
  80. Panthier, R., C. Lucasse, et C. Hannoun: Petite épidémie de fièvre jaune en Afrique Centrale en 1958 (District de Gemena, Province de l’Equateur, Congo- Léopoldville). Ann. Soc. beige Méd. trop. 42, 65—84 (1962).Google Scholar
  81. Peltier, M., C. Durieux, H. Jonchère, et E. Arquie: Pénétration du virus amaril neurotrope par voie cutanée. Vaccination mixte contre Ia fièvre jaune et Ia variole. (Note préliminaire). Bull. Acad. Méd. (Paris) 121, 657—660 (1939).Google Scholar
  82. Peltier, M.: Vaccin antiamaril et vaccinations antivariolo-amariles par Ia méthode dakaroise en Afrique Occidentale Franchaise. Proc. Intern. Congr. trop. Med. Malaria 4th 1, 489—497 (1948).Google Scholar
  83. Penna, H.A.: Production of 17D yellow fever vaccine. In: Yellow fever vaccination. Wld Hlth Org. Geneva 1956.Google Scholar
  84. Poison, A.: Particle size of yellow fever virus. Proc. Soc. exp. Biol. (N.Y.) 85, 613—615 (1954).Google Scholar
  85. Porterfield, J.S.: The haemagglutination- inhibition test in the diagnosis of yellow fever in man. Trans, roy. Soc. trop. Med. Hyg. 48, 261—266 (1954).Google Scholar
  86. Porterfield, J.S.: Further studies on the yellow fever haemagglutination test. Trans, roy. Soc. trop. Med. Hyg. 50, 344—353 (1956).Google Scholar
  87. Porterfield, J.S.: A plaque technique for the titration of yellow fever virus and antisera. Trans, roy. Soc. trop. Med. Hyg. 53, 458—466 (1959).Google Scholar
  88. Reagan, R.L., and A.L. Brueckner: Electron microscopy of yellow fever virus (17 D strain). Amer. J. Path. 29, 1157—1159 (1953).PubMedGoogle Scholar
  89. Reagan, R.L., S. Chang, and A.L. Brueckner: Study by electron microscopy of erythrocytes from Cave Bats (Myotus Cucifugus) infected intraperi- toneally with yellow fever virus (17D strain). Tex. Rep. Biol. Med. 13, 470—474 (1955).PubMedGoogle Scholar
  90. Da Rocha Lima, H.: Zur pathologischen Anatomie des Gelbfiebers. Verh. dtsch. path. Ges. 15, 163—181 (1912).Google Scholar
  91. De Roever-Bonnet, H., and J. Hoekstra: Yellow fever vaccination by scarification with 17D vaccine. Trop. geogr. Med. 10, 289—291 (1958).Google Scholar
  92. Romero, A., e A. Trejos: Clinica y laboratorio de la fiebre amarilla en Costa Rica. Rev. Biol. trop. (San José) 2, 113—168 (1954).Google Scholar
  93. Romero, A., e A. Trejos: Fiebre amarilla en ninos menores de doce anos. Rev. Biol. trop. (San José) 2, 169—174 (1954).Google Scholar
  94. Sawyer, W. A., and W. Lloyd: The use of mice in tests of immunity against yellow fever. J. exp. Med. 54, 533 (1931).PubMedCentralPubMedGoogle Scholar
  95. Sawyer, W. A., K.F. Meyer, M.D. Eaton, J.H. Bauer, P. Putnam, and F.F. Schwentker: Jaundice in Army personnel in western region of the United States and its relation to vaccination against yellow fever. Amer. J. Hyg. 39, 337—430 and 40, 35—107 (1944).Google Scholar
  96. Schindler, R., u. C. Hallauer: Prüfung von Gelbfiebervirus-Varianten aus menschlichen Gewebekulturen im AfFenversuch. Arch. ges. Virusforsch. 13, 345—357 (1963).PubMedGoogle Scholar
  97. Scott, L. G.: Encephalitis after yellow fever vaccination. Brit. med. J. 1954 II, 1108.Google Scholar
  98. Sellards, A.W.: Yellow fever. In: Stitts Diagnosis Prevention and Treatment of Tropical Diseases, p. 872.,Philadelphia 1943.Google Scholar
  99. Sérié, C.: The yellow fever epidemic in Ethiopia in 1959—1961.Google Scholar
  100. Sellards, A.W.: Ethiop. Med. J. 1, 28—32 (1962).Google Scholar
  101. Sellards, A.W.: Memorandum on yellow fever in Ethiopia, 1961—1962.Google Scholar
  102. Sellards, A.W.: Ethiop. Med. J. 1, 206—207 (1963).Google Scholar
  103. Sérié, C., L. Andral, A. Lindrec, et P. Néri: Epidémie de fièvre jaune en Ethiopie (1960—1962).Google Scholar
  104. Sellards, A.W.: Bull. Wld Hlth Org. 30, 299—319 (1964).Google Scholar
  105. Smith, C.E.G.: The distribution of antibodies to Japanese Encephalitis, Dengue and yellow fever viruses in five rural communities in Malaya. Trans, roy. Soc. trop. Med. Hyg. 51, 237—252 (1958).Google Scholar
  106. Smith, C.E.G., L.H. Turner, and P. Armitage: Yellow fever vaccination in Malaya by subcutaneous injection and multiple puncture. Neutralising antibody responses in persons with and without pre-existing antibody to related viruses. Bull. Wld Hlth Org. 27, 717—727 (1962).Google Scholar
  107. Smith, C.E.G., D. McMahon, and L.H. Turner: Yellow fever vaccination in Malaya by subcutaneous injection and multiple puncture. Haemagglutinin-inhibiting antibody responses in persons with and without previous antibody. Bull. Wld Hlth Org. 29, 75—80 (1963).Google Scholar
  108. Smith, H. H.: Controlling yellow fever. In: Yellow fever (G. K. Strode, edit.)., New York 1951.Google Scholar
  109. Smith, J.H.: Encephalitis in an infant after vaccination with 17D yellow fever virus. Brit, med. J. 1954 II, 852.Google Scholar
  110. Smithburn, K.C., A.J. Haddow, and W.H.R. Lumsden: An outbreak of sylvan yellow fever in Uganda with Aedes (Stegomyia) africanus Theobald as principal vector and insect host of the virus. Ann. trop. Med. Parasit. 43, 74—89 (1949).PubMedGoogle Scholar
  111. Smithburn, K.C.: Immunity. In: Yellow Fever (G. K. Strode, edit.).,New York 1951.Google Scholar
  112. Smithburn, K.C.: Immunology of yellow fever. In: Yellow fever vaccination. Wld Hlth Org. Geneva 1956.Google Scholar
  113. Soper, F.L., E.R. Rickard, and P. J. Crawford: The routine post-mortem removal of liver tissue from rapidly fatal fever cases for the discovery of silent yellow fever foci. Amer. J. Hyg. 19, 549—565 (1934).Google Scholar
  114. Soper, F. L.: The geographical distribution of immunity to yellow fever in man in South America. Amer. J. trop. Med. 17, 457—511 (1937).Google Scholar
  115. Soper, F. L.: Yellow fever: The present situation (October, 1938) with special reference to South America. Trans, roy. Soc. trop. Med. Hyg. 32, 297—322 (1938).Google Scholar
  116. Soper, F. L.: Erradicacion en las Americas de los invasores africanos Aedes aegypti y Anopheles gambiae. Bol. Ofic. sanit. panamer. 55, 259 (1963).PubMedGoogle Scholar
  117. Sprague, H.B., and J.H. Barnard: Egg allergy: Significance in typhus and yellow fever immunisation. U.S. nav. med. Bull. 45, 71—74 (1945).Google Scholar
  118. Stevenson, L.D.: Pathologic changes in the nervous system in yellow fever. Arch. Path. 27, 249 (1939).Google Scholar
  119. Stokes, A., J.H. Bauer, and P. Hudson: Experimental transmission of yellow fever to laboratory animals. Amer. J. trop. Med. 8, 103—164 (1928).Google Scholar
  120. Stones, P.B., and F.N. Macnamara: Encephalitis following neurotropic yellow fever vaccine administered by scarification in Nigeria: Epidemiological and laboratory studies. Trans, roy. Soc. trop. Med. Hyg. 49, 176—186 (1955).Google Scholar
  121. Strode, G.K.: Yellow fever (Gesamtdarstellung, mehrere Autoren). New York 1951.Google Scholar
  122. Stuart, J.: Reactions following vaccination against yellow fever. In: Yellow fever vaccination. Wld Hlth Org. Geneva 1956.Google Scholar
  123. Swartz, H.: Systemic allergic reaction induced by yellow fever vaccine. J. Lab. clin. Med. 28, 1663—1667 (1943).Google Scholar
  124. Symes, C.B., R.C. Muirhead Thompson, and J.R. Busvine: Insect control in public health. Amsterdam, New York, 1962.Google Scholar
  125. Theiler, M.: Studies on the action of yellow fever virus in mice. Ann. trop. Med. Parasit. 24, 249—272 (1930).Google Scholar
  126. Theiler, M.: A yellow fever protection test in mice by intracerebral injection. Ann. trop. Med. Parasit. 27, 57—77 (1933).Google Scholar
  127. Theiler, M., and H.H. Smith: The use of yellow fever virus modified bv in vitro cultivation for human immunisation. J. exp. Med. 65, 787—800 (1937).PubMedCentralPubMedGoogle Scholar
  128. Theiler, M.: The virus. In: Yellow fever (G. K. Strode, edit.). New York 1951.Google Scholar
  129. Theiler, M.: The epidemiological significance of the fundamental grouping of viruses. Amer. J. trop. Med. Hyg. 4, 627 (1955).Google Scholar
  130. Theiler, M., and J. Casals: The serological reactions in yellow fever. Amer. J. trop. Med. Hyg. 7, 585—594 (1958).Google Scholar
  131. Theiler, M.: Yellow fever. In: Viral and rickettsial infections of man (Th. M. Rivers and F.L. Horsfall, eds.). Philadelphia-Montreal: J.B. Lippincott & Co. 1959.Google Scholar
  132. Taylor, R.M.: Epidemiology. In: Yellow Fever (G. K. Strode, edit.). New York, 1951.Google Scholar
  133. Thomson, W.O.: Encephalitis in infants following vaccination with 17D yellow fever virus. Report of a further case. Brit. med. J. 1955 II, 182.Google Scholar
  134. Trejos, A., and A. Romero: Prothrombin levels in yellow fever. Rev. Biol. trop. (San José) 2, 69—73 (1954).Google Scholar
  135. UNRRA: Standards for the manufacture and control of yellow fever vaccine (zit. nach WHO, 1959). Epid. Inform. Bull. 1, 365 (1945).Google Scholar
  136. Wakeman, A.M., and C.A. Morrell: Chemistry and metabolism in experimental yellow fever in Macacus rhesus monkeys. Arch, intern. Med. 46, 290—305 (1930).Google Scholar
  137. Whitman, L.: The arthropod vectors of yellow fever. In: Yellow fever (G. K. Strode, edit.). New York, 1951.Google Scholar
  138. WHO:(World Health Organisation) Monograph Series No. 30, Geneva 1956, Yellow fever vaccination.Google Scholar
  139. WHO: (World Health Organisation) Chronicle 10, 39—45 (1956), New epidemiological aspects of yellow fever.Google Scholar
  140. WHO: (World Health Organisation) Techn. Rep. Ser. No. 136: Expert Committee on yellow fever vaccine, Geneva 1957Google Scholar
  141. WHO: (World Health Organisation) Techn. Rep. Ser. No. 179: Requirements for biological substances. 3. Requirements for yellow fever vaccine (1959).Google Scholar
  142. WHO: (World Health Organisation) Geneva: International Sanitary Regulations (1961).Google Scholar
  143. WHO: (World Health Organisation) Weekly Epid. Rec.: International Certificate of vaccination or revaccination against yellow fever 40, 252 (1965).Google Scholar
  144. WHO: (World Health Organisation) Weekly Epid. Rec.: Yellow fever 40, 618 (1965).Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1967

Authors and Affiliations

  • H. J. Knüttgen
    • 1
  1. 1.HamburgDeutschland

Personalised recommendations